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William Heberden on Angina Pectoris, 1 
But there is a disorder of the breast marked with 
strong and peculiar symptoms, considerable for 
the kind of danger belonging to it, and not 
extremely rare, which deserves to be mentioned 
more at length. The seat of it and the sense of 
strangling and anxiety with which it is attended, 
may make it not improperly be called angina 
pectoris. Those who are afflicted with it, are 
seized while they are walking (more especially if it 
be uphill, and soon after eating) with a painful 
and most disagreeable sensation in the breast, 
which seems as if it would extinguish life if it were 
to increase or to continue; but the moment they 
stand still, all this uneasiness vanishes. 
epi.umn.edu/cvdepi/essay/william-heberden-on-angina-pectoris-1772/ 
1772 
William Heberden on Angina Pectoris, 2 
In all other respects, the patients are, at the beginning of this 
disorder, perfectly well, and in particular have no shortness of 
breath, from which it is totally different.   
The pain is sometimes situated in the upper part, sometimes in 
the middle, sometimes in the bottom of the os. sterni, and often 
more inclined to the left than to the right side. It likewise very 
frequently extends from the breast to the middle of the left arm. 
The pulse is, at least sometimes, not disturbed by this pain, as I 
have had opportunities of observing by feeling the pulse during 
the paroxysm. Males are more liable to this disorder, especially 
such as have past their fiftieth year. After it has continued a year 
or more, it will not cease so instantaneously upon standing still; 
and it will come on not only when the persons are walking, but 
when they are lying down, especially if they lie on the left side 
and oblige them to rise out of their beds.  
epi.umn.edu/cvdepi/essay/william-heberden-on-angina-pectoris-1772/ 
William Heberden on Angina Pectoris, 3 
In some inveterate cases it has been brought on by the motion of 
a horse, or a carriage, and even by swallowing, coughing, going 
to stool or speaking, or any disturbance of mind. 
Such is the most usual appearance of this disease; but some 
varieties may be met with. Some have been seized while they 
were standing still, or sitting, also upon first waking out of sleep; 
and the pain sometimes reaches to the right arm, as well as to 
the left and even down to the hands, but this is uncommon; in a 
very few instances the arm has at the same time been numbed 
and swelled. In one or two persons the pain has lasted some 
hours or even days; but this happened when the complaint has 
been of long standing, and thoroughly rooted in the constitution; 
once only the very first attack continued the whole night. 
epi.umn.edu/cvdepi/essay/william-heberden-on-angina-pectoris-1772/ 
William Heberden on Angina Pectoris, 4 
I have seen nearly a hundred people under this disorder, of 
which number there have been three women and one boy 
twelve years old. All the rest were men near or past the fiftieth 
year of their age…  
The termination of the angina pectoris is remarkable. For if no 
accident interferes, but the disease goes on to its height, the 
patients all suddenly fall down, and perish almost immediately. 
Of which indeed their frequent faintness and sensations as if all 
the powers of life were failing, afford no obscure intimation. 
 
Heberden, W. 1772. Some account of a disorder of the breast. 
epi.umn.edu/cvdepi/essay/william-heberden-on-angina-pectoris-1772/ 
Plan of the Lecture   
• Definition 
• Epidemiology 
• Risk factors 
• Etiology 
• Mechanisms  
• Classification 
• Clinical investigation 
• Diagnosis 
• Treatment  
• Prognosis 
• Prophylaxis 
• Abbreviations  
• Guidelines 
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Definition  
Ischemic heart disease (IHD) or Coronary artery disease (CAD) is a 
group of diseases that characterized by impaired myocardial 
function due to decrease blood flow through the affected coronary 
arteries and includes silent ischemia, stable angina, unstable angina, 
myocardial infarction, and sudden cardiac death. 
Most IHD is caused by atherosclerotic vascular disease (ASVD), usually 
present even when the artery lumens appear normal by angiography. 
Stable forms of IHD (SIHD) include first two from the list 
SIHD cause narrowing of coronary arteries with chronic inadequate 
blood supply to the myocardium that can ultimately lead from silent 
ischemia to heart attacks with chest pain or discomfort known as stable 
angina pectoris most commonly experienced during physical and/or 
emotional distress. 
 
 en.wikipedia.org/wiki/Coronary_artery_disease 
Epidemiology   
(Coronary Artery Disease around the World ) 
nature.com/nrcardio/journal/v11/n5/full/nrcardio.2014.26.html 
The global distribution of ischaemic heart disease burden, in 
disability-adjusted life years (DALYs), in 2011. 
Epidemiology    
(Focus on Key Heart Diseases) 
The proportions of cardiovascular deaths (a) Men, (b) Women) 
caused by IHD, cerebrovascular disease, inflammatory heart 
disease, rheumatic heart disease, hypertensive heart disease, 
and other cardiovascular diseases in 2011.  
nature.com/nrcardio/journal/v11/n5/full/nrcardio.2014.26.html 
Risk Factors 
(Modifiable) 
en.wikipedia.org/wiki/Atherosclerosis 
• Diabetes or impaired glucose tolerance (IGT)   
• Dyslipoproteinemia: high serum concentration of low-density 
lipoprotein (LDL), and / or very low density lipoprotein (VLDL) 
particles; low serum concentration of functioning high density 
lipoprotein (HDL); an LDL:HDL ratio greater than 3:1 
• Tobacco smoking  
• Overweight and Obesity 
• Physical inactivity 
• Elevated serum C-reactive protein concentrations 
• Hypertension 
• Vitamin B6 deficiency 
• Dietary iodine deficiency and hypothyroidism  
Risk Factors 
(Nonmodifiable) 
en.wikipedia.org/wiki/Atherosclerosis 
• Advanced age 
• Male sex 
• Having close relatives who have had some complication of 
atherosclerosis (e.g. coronary heart disease or stroke) 
• Genetic abnormalities, e.g. familial hypercholesterolemia 
Risk Factors 
(Lesser or Uncertain) 
en.wikipedia.org/wiki/Atherosclerosis 
• Being of South Asian ethnicity   
• Hypercoagulability 
• Postmenopausal estrogen 
deficiency 
• High intake of saturated fat 
• Trans fat intake  
• High carbohydrate intake 
• Elevated serum levels 
of triglycerides 
• Elevated serum levels 
of homocysteine  
•  Elevated serum levels of uric 
acid  
• Elevated serum 
fibrinogen concentrations 
• Elevated serum lipoprotein 
concentrations 
• Chronic systemic inflammation  
• Elevated serum insulin levels  
• Short sleep duration 
• Chlamydia pneumoniae 
infection 
• Air pollution 
Risk Factors 
(Traditional versus Nontraditional Risk Factors) 
emedicine.medscape.com/article/164163-overview 
The expanding list of nontraditional biomarkers is outweighed by the 
standard risk factors for predicting future cardiovascular events and adds only 
moderately to standard risk factors. BNP = B-type natriuretic peptide; BP = 
blood pressure; CRP = C-reactive protein; HDL = high-density lipoprotein 
cholesterol; HIV = human immunodeficiency virus infection. 
Risk Factors 
(Factors That Have an Impact on the IHD Events’ Risk) 
content.onlinejacc.org/article.aspx?articleid=1140128 
Mechanisms   
(Key Moments)     
pathophys.org/acs/ 
• Chronic myocardial ischemia is a consequence of reduced blood 
flow in coronary arteries, due to a combination of fixed vessel 
narrowing and abnormal vascular tone as a result 
of ASVD and endothelial dysfunction with an imbalance 
between myocardial oxygen supply and demand:  
• The degree and the length of vessel narrowing affect the 
hemodynamic significance of a stenotic lesion 
• Endothelial dysfunction contributes to myocardial ischemia 
in inappropriate vasoconstriction of coronary arteries   
• Non-ASVD causes of myocardial ischemia include  decreased 
coronary perfusion pressure due to hypotension; decreased 
blood oxygen content due to marked anemia and pulmonary 
disease, unusual (e.g. congenital) coronary abnormalities, etc.   
Mechanisms   
(Myocardial Ischemia begets more Ischemia)     
onlinelibrary.wiley.com/doi/10.1002/clc.20048/pdf 
Factors Important in SIHD 
Mechanisms   
(Myocardial Ischemia begets more Ischemia)     
onlinelibrary.wiley.com/doi/10.1002/clc.20048/pdf 
Factors Important in SIHD 
Mechanisms   
(miRNAs and their targets in Cardiac Ischemia)     
physrev.physiology.org/content/91/3/827 
The different miRNAs (posttranscriptional regulators) and their 
targets that are involved in cell viability, angiogenesis, fibrosis, 
and electrical remodeling during cardiac ischemia.  
Classification 
(International Classification of Diseases (ICD)) 
apps.who.int/classifications/icd10/browse/2016/en#/I20-I25 
Chapter IX 
Diseases of the circulatory system 
(I00-I99)  
I20-I25 Ischaemic heart diseases 
              I20.1 Angina pectoris with documented spasm 
                        Angina (angiospastic, Prinzmetal, spasm-induced, variant) 
              I20.8 Other forms of angina pectoris 
         Angina of effort 
                        Coronary slow flow syndrome 
                        Stable angina 
                        Stenocardia 
              I20.9 Angina pectoris, unspecified 
         Angina ( NOS (not otherwise specified), cardiac) 
                        Anginal syndrome 
                        Ischaemic chest pain 
 
 
   
 
Classification 
(Canadian Cardiac Society Angina Class Scale (C CSA))  
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/coronary-artery-disease/ 
Classification 
(from Stable Angina until Accelerating Angina) 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/coronary-artery-disease/ 
• Angina is stable when its pattern of frequency, intensity, 
ease of provocation, or duration does not change over a 
period of several weeks. Identification of activities that 
provoke angina and the amount of sublingual nitroglycerin 
required to relieve symptoms are helpful indicators of 
stability versus progression.  
• Angina is accelerating when there is a change in the 
pattern of stable angina. This may include a greater ease of 
provocation, more prolonged episodes, and episodes of 
greater severity, requiring a longer recovery period or 
more frequent use of sublingual nitroglycerin. This 
suggests a transition and most likely reflects a change in 
coronary artery blood flow and perfusion of the 
myocardium.   
Clinical Investigation  
(Passions around Symptoms) 
• Chest pain (angina) can be described as a heaviness, pressure, 
aching, burning, numbness, fullness, squeezing, discomfort or 
painful feeling in the chest, but may also be felt in the 
left shoulder, arms, neck, back, or jaw. 
• Shortness of breath. 
• Palpitations. 
• Weakness or dizziness. 
• Nausea. 
• Sweating. 
• Some patients have no signs or symptoms (silent ischemia) until 
there will be developed symptoms of a heart attack, heart 
failure, or an arrhythmia.   
webmd.com 
Clinical Investigation  
(Common Locations and Patterns of  Angina Pain) 
s3.amazonaws.com/classconnection/12/flashcards/9384012/png/angina-153389544C30E11EA69.png eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
The characteristics of discomfort-related to angina may be divided into four categories: 
location, character, duration and relationship to exertion and other exacerbating or 
relieving factors. The discomfort caused by myocardial ischaemia is usually located in the 
chest, near the sternum, but may be felt anywhere from the epigastrium to the lower jaw 
or teeth, between the shoulder blades or in either arm to the wrist and fingers. 
Clinical Investigation  
(Traditional Clinical Classification of Chest Pain) 
Typical angina  
(definite) 
Meets all three of the following 
characteristics:  
• substernal chest discomfort of 
characteristic quality and duration;  
• provoked by exertion or emotional 
stress; • relieved by rest and/or nitrates 
within minutes. 
Atypical angina 
(probable)  
Meets two of these characteristics. 
Non-anginal 
chest pain  
Lacks or meets only one or none of the 
characteristics. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Clinical Investigation  
(Hallmark of Prinzmetal Angina) 
• In contrast to patient with stable angina secondary to coronary 
atherosclerosis, patients with Prinzmetal (variant) angina (until 
10% of angina patients)  are younger and have fewer coronary 
risk factors (except smoking). 
• Episode of chest pain usually does not progress from a period of 
chronic stable angina. 
• Cardiac examination is normal in the absence of ischemia. 
• Symptoms occur at rest (usually at night), rather than on 
exertion.  
• 2/3 of patients have concurrent atherosclerosis of a 
major coronary artery, but this is often mild or not in proportion 
to the degree of symptoms.  
en.wikipedia.org/wiki/Prinzmetal%27s_angina 
Clinical Investigation  
(Passions around Cardiac Syndrome X) 
• Cardiac syndrome X is angina associated with decreased blood 
flow to the heart tissue with normal coronary arteries and 
referred to microvascular dysfunction. 
• Angina is most of the time unpredictable and it can occur when 
at rest and/or during exercise.  
• Pain is normally more intense and it lasts for longer periods of 
time compared to pain caused by other conditions.  
• Some studies have found increased risk of other vasospastic 
disorders, such as migraine and Raynaud's phenomenon.  
• It is treated with beta-blockers and usually carries a favorable 
prognosis. 
• This is a distinct diagnosis from Prinzmetal angina. 
en.wikipedia.org/wiki/Cardiac_syndrome_X 
Clinical Investigation  
(Stable Angina versus Myocardial Infarction 
Comparison Chart) 
diffen.com/difference/Myocardial_Infarction_vs_Stable_Angina 
Symptoms Myocardial Infarction Stable Angina 
Occurrence of 
pain 
Occurs at any time Occurs due to physical  or 
emotional stress 
Modality of 
pain 
With damage to the heart 
and usually described as 
severe, steady, and crushing  
With no damage to the heart   
Outcome May be fatal Usually not fatal 
Relieving 
factors of pain 
Symptoms persists after 15 
min. and not relieved by 
rest or nitro  
Symptoms relieved by rest or 
nitro within 10-15 min.  
Duration of 
pain 
Usually lasts for more than 
15 min. 
Usually for less than 15 min.; 
discomfort is transient, lasting 3-
5 min. 
Serum cardiac 
marker 
Present Not present 
Clinical Investigation  
(History) 
• The history should include any current symptoms and a 
complete inventory of comorbid conditions.  
• An inventory of cardiac risk factors, and a complete family 
history are essential components.  
• The history should also include information about the character 
and location of discomfort, radiation of discomfort, associated 
symptoms, and precipitating, exacerbating, or alleviating factors.  
• The importance of the family history should not be 
underestimated.  
• A detailed assessment, particularly of first-degree relatives for 
the presence of IHD and age of diagnosis is imperative when 
evaluating a patient's risk factor profile. 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/coronary-artery-disease/ 
Clinical Investigation  
(Physical Examination 1) 
• The results of the physical examination of a patient may be 
entirely normal.  
• The presence of multiple risk factors or atherosclerosis in the 
carotid or peripheral arteries increases the likelihood that a 
chest pain syndrome is related to myocardial ischemia.  
• Evaluation should include measurements of blood pressure 
and the ankle-brachial index.  
• Examination of the carotid arteries should include 
auscultation for bruits.  
• Examination of the chest wall, neck, and shoulders for 
deformities and tenderness may be helpful in diagnosing 
musculoskeletal chest discomfort.   
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/coronary-artery-disease/ 
Clinical Investigation  
(Physical Examination 2) 
• Cardiac auscultation may detect murmurs caused by aortic 
stenosis or hypertrophic cardiomyopathy, either of which 
can cause angina in the absence of IHD.  
• Assessment of the abdominal aorta for an aneurysm or 
bruits and palpation of lower extremity pulses is necessary 
to evaluate for peripheral vascular disease.  
• Careful palpation of all peripheral pulses and assessment of 
symmetry versus diminution are also valuable noninvasive 
approaches for assessing the integrity of the arterial 
circulation.  
• Finally, examination for xanthelasmas, tendon xanthomas, 
retinal arterial abnormalities, and peripheral neuropathy can 
be helpful. 
clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/coronary-artery-disease/ 
Diagnosis 
  
• Electrocardiogram (ECG): reveal  evidence of a previous heart 
attacks 
• B-mode, Doppler and intravascular ultrasound: degree of any 
blockages in arteries 
• Ankle-brachial index: recognition of peripheral vascular disease, 
which is usually caused by atherosclerosis 
• Stress test (including echocardiogram): reveal  evidence of a chronic 
coronary artery disease 
• Ambulatory ECG 
•  Vascular catheterization and angiogram: reveal  evidence of 
narrowed, blocked or aneurismatic arteries 
• Other imaging tests (CT, MRA, etc.): reveal  evidence of narrowed or 
blocked arteries, as well as aneurysms and calcium deposits in the 
artery walls 
• Blood tests: cholesterol and C-reactive protein levels, 
lipoproteinogram  
 
en.wikipedia.org/wiki/Coronary_artery_disease#Diagnosis 
Diagnosis 
(Electrocardiogram)  
An old post-infarction scar of the front wall (deep Q in V1- V4). The 
situation is most probably complicated by a suspected ventricular 
aneurysm. ST sections for QRS in V1 -V4 are elevated, best seen in V4 
where the elevation reminds the Pardee’s wave (underlined in red). 
health-tutor.com/myocardial-scar-ecg.html 
Diagnosis 
(Ultrasound)  
Images of the left main coronary artery (LMCA) and proximal the left anterior 
descending coronary artery (LAD - pLAD). The left parasternal position, a 
modified parasternal short axis view of great vessels, Nyquist limit is 20-67 
cm/s. A – LMCA, B-mode; B – pLAD, B-mode; C – LMCA, Color Doppler 
mapping; D - bifurcation of the LMCA; Color Doppler mapping.   
health-tutor.com/myocardial-scar-ecg.html 
Diagnosis 
(Stress test)  
54-year-old male, with a chest pain during exercise (II C CSA) underwent 
an exercise stress test. ECG demonstrated  an increase in R wave 
amplitude from V1 to V4, and minor ST segment depression in DII, DIII 
and aVF.  Coronary angiogram showed a critical proximal left anterior 
descending artery lesion. 
cogprints.org/4806/1/uchida.htm 
Diagnosis 
(Ambulatory ECG)  
AECG recording in Prinzmetal 
angina. A. Control. Lead II (top), 
precordial lead (bottom). B. 
Marked ST-segment elevation, 
associated with mild angina. C. 
High-grade atrioventricular block 
and continued ST-segment 
elevation, associated with near 
syncope. D. Nonsustained 
ventricular tachycardia with 
continued ST-segment elevation 
associated with palpitations and 
light-headedness. 
medscape.com/viewarticle/463306 
Diagnosis 
(Vascular catheterization and angiogram)  
The finger (top left) is pointing to the narrowed region of a 
dye-filled coronary artery. 
atrainceu.com/course-all/coronary-artery-disease-cad-041 
Diagnosis 
(Coronary computed tomography angiography)  
Evaluation of vena saphena graft to right coronary artery. Note 
the permeable graft (double asterisks) and the anastomosis 
with the right coronary artery (single asterisk) ( A ). 3D 
reconstruction ( B ).  
.scielo.br/scielo.php?script=sci_arttext&pid=S0100-39842016000100026 
Treatment 
(Lifestyle Changes) 
• Salt restriction  
• Moderation of alcohol consumption 
• Other dietary changes (vegetables, low-fat dairy 
products, dietary and soluble fibers, whole grains 
and protein from plant sources, reduced in 
saturated fat and cholesterol) 
• Weight reduction 
• Regular physical exercise 
• Smoking cessation  
 
emedicine.medscape.com/article/198475-overview#a3  
Treatment 
(Education) 
• There should be a change in focus in the education of all 
physicians to more strongly emphasize evidence based 
primary prevention of SIHD as a part of ASVD  
• Education focused on school children, especially targeted 
to create sustainable healthy behavior and sustainable 
control of risk factors 
• Telemedicine has been proven effective in selected world 
regions 
• Engage the media to promote education for SIHD and 
ASVD  prevention, and the need for rapid access to 
treatment 
• Produce easily accessible (through medical journals and 
internet) guidelines for management of IHD and ASVD   
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Treatment 
(Pharmacotherapy Aims) 
The two aims of the 
pharmacotherapy 
of SIHD patients are 
to obtain relief of 
symptoms and to 
prevent 
cardiovascular (CV) 
events.   
 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf ehjcimaging.oxfordjournals.org/content/14/8/721 
Treatment 
(Pharmacotherapy Medications 1) 
Medications for risk factors and ischemia management:  
• Nitrates,  
• Beta-blockers, 
• Calcium channel blockers, 
•  ivabradine, 
• Nicorandil, 
• Trimetazidine, 
• Ranolazine, 
• Allopurinol, 
• Molsidomine. 
 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Nitrates 1) 
Short-acting nitrates for acute effort angina: 
• Sublingual nitroglycerin is the standard initial therapy for 
effort angina. When angina starts, the patient should rest 
sitting and take sublingual nitroglycerin (0.3–0.6 mg) 
every 5 min until the pain goes or a maximum of 1.2 mg 
has been taken within 15 min. Nitroglycerin spray acts 
more rapidly. Nitroglycerin can be used prophylactically 
when angina can be expected, such as activity after a 
meal, emotional stress, sexual activity and in colder 
weather. 
• Isosorbide dinitrate (5 mg sublingually) helps to abort 
anginal attacks for about 1 h.   
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Nitrates 2) 
• Long-acting nitrates (isosorbide dinitrate, mononitrates, 
transdermal nitroglycerin patches) for angina prophylaxis 
are not continuously effective if regularly taken over a 
prolonged period without a nitrate-free or nitrate-low 
interval of about 8–10 hours (tolerance).  
• Worsening of endothelial dysfunction is a potential 
complication of long-acting nitrates, hence the common 
practice of the routine use of long-acting nitrates as first 
line therapy for patients with effort angina needs re-
evaluation.  
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Beta-blockers) 
Beta-blockers act directly on the heart to reduce heart rate, 
contractility, atrioventricular (AV) conduction and ectopic 
activity.  
Additionally, they may increase perfusion of ischaemic areas 
by prolonging the diastole and increasing vascular resistance 
in non-ischaemic areas.  
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Calcium channel blockers) 
• Calcium channel blockers (calcium antagonists) act chiefly 
by vasodilation and reduction of the peripheral vascular 
resistance.  
• Calcium channel blockers can chemically be classified into 
the dihydropyridines and the non- dihydropyridines, their 
common pharmacological property being selective 
inhibition of L-channel opening in vascular smooth muscle 
and in the myocardium. 
• The non- dihydropyridines, by virtue of nodal inhibition, 
tend to reduce the heart rate (heart rate-lowering agents, 
verapamil and diltiazem) and explain the anti-anginal 
properties. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Ivabradine) 
• Ivabradine is a heart rate-lowering agent selectively 
inhibiting the sinus node I(f) pacemaking current, thereby 
decreasing the myocardial oxygen demand without effect 
on inotropism/ 
• The effect was predominant in patients with a heart rate 
≥70 bpm. 
• Ivabradine is an effective anti-anginal agent, alone or in 
combination with b-blockers. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Nicorandil) 
• Nicorandil is a nitrate derivative of nicotinamide that can 
be used for the prevention and long-term treatment of 
angina, and may be added after beta-blockers and calcium 
antagonists. 
• Long-term use of oral nicorandil may stabilize coronary 
plaque in patients with stable angina. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Trimetazidine) 
• Trimetazidine is an anti-ischaemic metabolic modulator, 
with similar anti-anginal efficacy to propranolol in doses of 
20 mg thrice daily.  
• The heart rate and rate × pressure product at rest and at 
peak exercise remained unchanged in the trimetazidine 
group, thus showing a non-mechanical anti-ischaemic 
action. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Ranolazine) 
• Ranolazine is a selective inhibitor of late sodium current 
with anti-ischaemic and metabolic properties. 
• Ranolazine can be added to other well-established anti-
anginal drugs, in particular in patients with higher HbA1c 
levels, who may also more often rely on medical 
management. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Allopurinol) 
• Allopurinol, an inhibitor of xanthine oxidase that reduces 
uric acid in persons with gout, is also anti-anginal.  
• Allopurinol additionally reduced vascular oxidative stress. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Molsidomine) 
• This direct NO donor has anti-ischaemic effects similar to 
those of isosorbide dinitrate. 
• The long-acting once-daily 16 mg formulation is as 
effective as 8 mg twice daily. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Pharmacotherapy Medications 2) 
Medications for event prevention:  
• Antiplatelet agents (low-dose aspirin, P2Y12 inhibitors 
(thienopyridines) and their combinations). 
• Lipid-lowering agents (statins). 
• Renin-angiotensin-aldosterone system blockers. 
 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Antiplatelet Agents) 
• Antiplatelet agents decrease platelet aggregation and 
may prevent formation of coronary thrombus.  
• Due to a favorable ratio between benefit and risk in 
patients with SIHD and its low cost, low-dose aspirin is 
the drug of choice in most cases and clopidogrel may be 
considered for some patients.  
• The use of antiplatelet agents is associated with a higher 
bleeding risk. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Lipid-lowering Agents) 
• Patients with documented CAD are regarded as being at 
very high risk and should be treated with statins. 
• The treatment target is LDL-C ,1.8 mmol/L and/or more 
than 50% reduction if the target level cannot be reached. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Renin-Angiotensin-Aldosterone System Blockers) 
• Angiotensin converting enzyme (ACE) inhibitors reduce 
total mortality, myocardial infarction, stroke and heart 
failure among specific subgroups of patients, including 
those with heart failure, previous vascular disease alone, 
or high-risk diabetes. 
• Hence, it is appropriate to consider ACE inhibitors for the 
treatment of patients with SIHD, especially with co-
existing hypertension, left ventricle ejection fraction 
≤40%, diabetes or chronic kidney disease, unless contra-
indicated. 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf 
Treatment 
(Revascularization) 
• Percutaneous coronary 
intervention 
• Coronary artery bypass 
surgery 
• Revascularization vs. 
medical therapy 
eurheartj.oxfordjournals.org/content/ehj/34/38/2949.full.pdf emedicine.medscape.com/article/164682-overview 
Prognosis  
• Long-term prognosis in the individual patient is unpredictable.  
• There are indications that the course of coronary heart 
disease may be modified, and that the pattern of survival may 
begin to approach that of the average population by 
controlling some of the predisposing factors, and by 
application of such measures as dietary restriction of fat and 
prolonged anticoagulation. 
sciencedirect.com/science/article/pii/0002870359901619 
Prophylaxis 
• Risk factor assessment and modification should begin early in 
life (childhood) 
• Most risk factors can be modified by lifestyle changes as 
opposed to drug or device treatment 
• Solidarity in primary prevention efforts will benefit both the 
individual and the society as a whole 
• Effective treatment reduces the first clinical manifestations of 
SIHD and ASVD   
• The role of Governments is crucial   
• Aggregate risk factor reduction can decrease cardiovascular 
events by as much as 70% 
• Adequate Secondary prevention measures can reduce 
vascular event recurrence by 75% 
casinapioiv.va/content/dam/accademia/pdf/atherosclerosis.pdf 
Abbreviations  
• ACE - angiotensin converting 
enzyme 
• ASVD – atherosclerotic 
vascular disease  
• CT – computer tomography 
• CV - cardiovascular 
• CAD -coronary artery disease 
• ECG – electrocardiography 
• ICD - International 
Classification of Diseases 
 
 
• IGT - impaired glucose 
tolerance  
• IHD - ischemic heart disease 
• HDL – high-density lipoprotein 
• LDL - low-density lipoprotein  
• MRA –  magnetic resonance 
angiogram 
• miRNAs - posttranscriptional 
regulators    
• SIHD – stable forms of  
ischemic heart disease 
 
 
Diagnostic and treatment guidelines 
Europe 
• 2013 ESC guidelines on the management of stable 
coronary artery disease  
• Joint 2016 European Guidelines on Cardiovascular 
Disease Prevention in Clinical Practice 
North America 
• 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update 
of the Guideline for the Diagnosis and Management of 
Patients With Stable Ischemic Heart Disease 
•  2016 ACC/AHA Guideline Focused Update on Duration 
of Dual Antiplatelet Therapy in Patients With Coronary 
Artery Disease 
 
 
 
 
 
